These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3706107)

  • 1. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
    Raeder EA; Verrier RL; Lown B
    Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
    Shargorodsky BM; Braun S; Belhassen B; Laniado S
    Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
    Gerold M; Eigenmann R; Haeusler G
    J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by the calcium antagonist tiapamil, against cardiac lymphatic enzyme leakage and arrhythmias in canine hearts during reperfusion.
    Matsuura A; Ishihara T; Nakamura K; Himori N; Nakamura K
    J Cardiovasc Pharmacol; 1986; 8(1):90-8. PubMed ID: 2419700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
    Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
    Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon.
    Rogers GG; Rosendorff C; Shimell CJ; Coull A
    Cardiology; 1982; 69 Suppl():58-67. PubMed ID: 7151084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium blockers on ventricular fibrillation during acute myocardial infarction.
    Da-Luz PL; Da-Silveira MC; Murad-Neto A; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):801-10. PubMed ID: 3266473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
    Billman GE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart.
    Pelleg A; Pardo Y; Belhassen B; Shargordsky B; Chagnac A; Laniado S
    Cardiology; 1985; 72(4):193-201. PubMed ID: 3876883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
    Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tiapamil on canine myocardial infarct size.
    Kordenat K; Leasure J
    Am Heart J; 1986 Mar; 111(3):502-12. PubMed ID: 3953359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiapamil--a new calcium antagonist.
    Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
    S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
    Corbalan R; Verrier RL; Lown B
    Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic changes after tiapamil in coronary and noncoronary patients.
    Burkart F; Bertel O; Baitsch G; Cocco G
    Cardiology; 1982; 69 Suppl():124-9. PubMed ID: 7151073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative inotropic effects of tiapamil (Ro11-1781) and verapamil in rabbit myocardium.
    Harada S; Sada H; Kojima M; Ban T
    Eur J Pharmacol; 1982 Feb; 78(1):7-14. PubMed ID: 7075665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.